Biology and Targetability of the Extended Spectrum of PIK3CA Mutations Detected in Breast Carcinoma

por Rugo, Hope S., Raskina, Kira, Schrock, Alexa B., Madison, Russell W., Graf, Ryon P., Sokol, Ethan S., Sivakumar, Smruthy, Lee, Jessica K., Fisher, Virginia, Oxnard, Geoffrey R., Tukachinsky, Hanna
Publicado 2023

APOBEC Mutational Signatures in Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors an...

por Sammons, Sarah, Raskina, Kira, Danziger, Natalie, Alder, Laura, Schrock, Alexa B., Venstrom, Jeffrey M., Knutson, Keith L., Thompson, E. Aubrey, McGregor, Kim, Sokol, Ethan, Chumsri, Saranya
Publicado 2022

Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies

por Zurita, Amado J., Graf, Ryon P., Villacampa, Guillermo, Raskina, Kira, Sokol, Ethan, Jin, Dexter, Antonarakis, Emmanuel S., Li, Gerald, Huang, Richard S. P., Casanova-Salas, Irene, Vivancos, Ana, Carles, Joan, Ross, Jeffrey S., Schrock, Alexa B., Oxnard, Geoffrey R., Mateo, Joaquin
Publicado 2022

Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy by Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer

por Graf, Ryon P., Fisher, Virginia, Weberpals, Janick, Gjoerup, Ole, Tierno, Marni B., Huang, Richard S. P., Sayegh, Nicolas, Lin, Douglas I., Raskina, Kira, Schrock, Alexa B., Severson, Eric, Haberberger, James F., Ross, Jeffrey S., Creeden, James, Levy, Mia A., Alexander, Brian M., Oxnard, Geoffrey R., Agarwal, Neeraj
Publicado 2022